(RGR) Sturm Ruger - Overview
Sector: IndustrialsIndustry: Aerospace & Defense | Exchange NYSE (USA) | Currency USD | Market Cap: 622m | Total Return 11.9% in 12m
Stock: Firearms, Rifles, Pistols, Revolvers, Accessories
Total Rating 45
Risk 79
Buy Signal 0.71
| Risk 5d forecast | |
|---|---|
| Volatility | 42.0% |
| Relative Tail Risk | -15.8% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.39 |
| Alpha | 2.33 |
| Character TTM | |
|---|---|
| Beta | 0.430 |
| Beta Downside | 0.634 |
| Drawdowns 3y | |
|---|---|
| Max DD | 48.65% |
| CAGR/Max DD | -0.13 |
EPS (Earnings per Share)
Revenue
Description: RGR Sturm Ruger March 05, 2026
Sturm, Ruger & Company, Inc. (RGR) designs, manufactures, and sells firearms and related accessories in the United States. The company operates in two segments: Firearms and Castings.
The Firearms segment produces a range of firearms including rifles, pistols, and revolvers, sold primarily to the commercial sporting market through wholesale distributors. This segment also manufactures lever-action rifles under the Marlin brand. The U.S. consumer firearms market is a significant component of the broader leisure products sector.
The Castings segment manufactures steel investment castings and metal injection molding (MIM) parts, sold directly or through representatives. This business model diversifies revenue streams beyond firearm sales.
Ruger was founded in 1949 and is headquartered in Southport, Connecticut. For a deeper analysis of RGRs financial performance and market position, continue your research on ValueRay.
Headlines to watch out for
- Firearm demand fluctuates with political climate and consumer sentiment
- Raw material costs impact manufacturing profitability
- Regulatory changes on firearm sales increase compliance burden
- Competition from other firearm manufacturers affects market share
- Casting segment revenue diversifies company income
Piotroski VR‑10 (Strict, 0-10) 5.5
| Net Income: -4.39m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.11 > 0.02 and ΔFCF/TA 2.22 > 1.0 |
| NWC/Revenue: 28.73% < 20% (prev 36.88%; Δ -8.16% < -1%) |
| CFO/TA 0.16 > 3% & CFO 54.3m > Net Income -4.39m |
| Net Debt (-16.6m) to EBITDA (7.92m): -2.10 < 3 |
| Current Ratio: 3.87 > 1.5 & < 3 |
| Outstanding Shares: last quarter (16.6m) vs 12m ago -1.17% < -2% |
| Gross Margin: 14.86% > 18% (prev 0.21%; Δ 1.46k% > 0.5%) |
| Asset Turnover: 150.4% > 50% (prev 139.5%; Δ 10.94% > 0%) |
| Interest Coverage Ratio: -86.34 > 6 (EBITDA TTM 7.92m / Interest Expense TTM 94.0k) |
Altman Z'' 10.00
| A: 0.46 (Total Current Assets 211.6m - Total Current Liabilities 54.7m) / Total Assets 342.0m |
| B: 1.23 (Retained Earnings 422.0m / Total Assets 342.0m) |
| C: -0.02 (EBIT TTM -8.12m / Avg Total Assets 363.0m) |
| D: 7.67 (Book Value of Equity 446.5m / Total Liabilities 58.2m) |
| Altman-Z'' Score: 14.93 = AAA |
Beneish M -4.00
| DSRI: 0.94 (Receivables 64.5m/67.1m, Revenue 546.1m/535.6m) |
| GMI: 1.44 (GM 14.86% / 21.36%) |
| AQI: -7.77 (AQ_t -1.10 / AQ_t-1 0.14) |
| SGI: 1.02 (Revenue 546.1m / 535.6m) |
| TATA: -0.17 (NI -4.39m - CFO 54.3m) / TA 342.0m) |
| Beneish M-Score: -8.04 (Cap -4..+1) = AAA |
What is the price of RGR shares?
As of March 26, 2026, the stock is trading at USD 43.53 with a total of 439,572 shares traded.
Over the past week, the price has changed by +12.51%, over one month by +19.71%, over three months by +35.22% and over the past year by +11.94%.
Over the past week, the price has changed by +12.51%, over one month by +19.71%, over three months by +35.22% and over the past year by +11.94%.
Is RGR a buy, sell or hold?
Sturm Ruger has received a consensus analysts rating of 5.00.
Therefore, it is recommended to buy RGR.
- StrongBuy: 1
- Buy: 0
- Hold: 0
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the RGR price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 45.5 | 4.5% |
| Analysts Target Price | 45.5 | 4.5% |
RGR Fundamental Data Overview March 24, 2026
P/E Forward = 8.6133
P/S = 0.8505
P/B = 2.1903
Revenue TTM = 546.1m USD
EBIT TTM = -8.12m USD
EBITDA TTM = 7.92m USD
Long Term Debt = 1.16m USD (from capitalLeaseObligations, last quarter)
Short Term Debt = 647k USD (from shortTermDebt, last quarter)
Debt = 1.80m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -16.6m USD (from netDebt column, last quarter)
Enterprise Value = 530.8m USD (621.5m + Debt 1.80m - CCE 92.5m)
Interest Coverage Ratio = -86.34 (Ebit TTM -8.12m / Interest Expense TTM 94.0k)
EV/FCF = 13.80x (Enterprise Value 530.8m / FCF TTM 38.5m)
FCF Yield = 7.25% (FCF TTM 38.5m / Enterprise Value 530.8m)
FCF Margin = 7.04% (FCF TTM 38.5m / Revenue TTM 546.1m)
Net Margin = -0.80% (Net Income TTM -4.39m / Revenue TTM 546.1m)
Gross Margin = 14.86% ((Revenue TTM 546.1m - Cost of Revenue TTM 464.9m) / Revenue TTM)
Gross Margin QoQ = 17.84% (prev 15.11%)
Tobins Q-Ratio = 1.55 (Enterprise Value 530.8m / Total Assets 342.0m)
Interest Expense / Debt = 2.16% (Interest Expense 39.0k / Debt 1.80m)
Taxrate = 24.14% (1.11m / 4.59m)
NOPAT = -6.16m (EBIT -8.12m * (1 - 24.14%)) [loss with tax shield]
Current Ratio = 3.87 (Total Current Assets 211.6m / Total Current Liabilities 54.7m)
Debt / Equity = 0.01 (Debt 1.80m / totalStockholderEquity, last quarter 283.8m)
Debt / EBITDA = -2.10 (Net Debt -16.6m / EBITDA 7.92m)
Debt / FCF = -0.43 (Net Debt -16.6m / FCF TTM 38.5m)
Total Stockholder Equity = 293.6m (last 4 quarters mean from totalStockholderEquity)
RoA = -1.21% (Net Income -4.39m / Total Assets 342.0m)
RoE = -1.50% (Net Income TTM -4.39m / Total Stockholder Equity 293.6m)
RoCE = -2.75% (EBIT -8.12m / Capital Employed (Equity 293.6m + L.T.Debt 1.16m))
RoIC = -2.10% (negative operating profit) (NOPAT -6.16m / Invested Capital 293.6m)
WACC = 7.48% (E(621.5m)/V(623.3m) * Re(7.50%) + D(1.80m)/V(623.3m) * Rd(2.16%) * (1-Tc(0.24)))
Discount Rate = 7.50% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.92%
Shares Correlation 3-Years: -100.0 | Cagr: -3.09%
[DCF] Terminal Value 77.77% ; FCFF base≈37.0m ; Y1≈31.0m ; Y5≈23.1m
[DCF] Fair Price = 30.85 (EV 475.2m - Net Debt -16.6m = Equity 491.9m / Shares 15.9m; r=7.48% [WACC]; 5y FCF grow -19.58% → 3.0% )
EPS Correlation: -86.37 | EPS CAGR: -39.39% | SUE: -1.04 | # QB: 0
Revenue Correlation: -40.25 | Revenue CAGR: -2.57% | SUE: 1.05 | # QB: 1
EPS next Quarter (2026-06-30): EPS=0.47 | Chg7d=+0.015 | Chg30d=+0.015 | Revisions Net=-1 | Analysts=2
EPS current Year (2026-12-31): EPS=1.90 | Chg7d=-0.025 | Chg30d=-0.025 | Revisions Net=+0 | Growth EPS=+125.6% | Growth Revenue=+1.4%
[Analyst] Revisions Ratio: -1.00 (0 Up / 1 Down within 30d for Next Quarter)
P/S = 0.8505
P/B = 2.1903
Revenue TTM = 546.1m USD
EBIT TTM = -8.12m USD
EBITDA TTM = 7.92m USD
Long Term Debt = 1.16m USD (from capitalLeaseObligations, last quarter)
Short Term Debt = 647k USD (from shortTermDebt, last quarter)
Debt = 1.80m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -16.6m USD (from netDebt column, last quarter)
Enterprise Value = 530.8m USD (621.5m + Debt 1.80m - CCE 92.5m)
Interest Coverage Ratio = -86.34 (Ebit TTM -8.12m / Interest Expense TTM 94.0k)
EV/FCF = 13.80x (Enterprise Value 530.8m / FCF TTM 38.5m)
FCF Yield = 7.25% (FCF TTM 38.5m / Enterprise Value 530.8m)
FCF Margin = 7.04% (FCF TTM 38.5m / Revenue TTM 546.1m)
Net Margin = -0.80% (Net Income TTM -4.39m / Revenue TTM 546.1m)
Gross Margin = 14.86% ((Revenue TTM 546.1m - Cost of Revenue TTM 464.9m) / Revenue TTM)
Gross Margin QoQ = 17.84% (prev 15.11%)
Tobins Q-Ratio = 1.55 (Enterprise Value 530.8m / Total Assets 342.0m)
Interest Expense / Debt = 2.16% (Interest Expense 39.0k / Debt 1.80m)
Taxrate = 24.14% (1.11m / 4.59m)
NOPAT = -6.16m (EBIT -8.12m * (1 - 24.14%)) [loss with tax shield]
Current Ratio = 3.87 (Total Current Assets 211.6m / Total Current Liabilities 54.7m)
Debt / Equity = 0.01 (Debt 1.80m / totalStockholderEquity, last quarter 283.8m)
Debt / EBITDA = -2.10 (Net Debt -16.6m / EBITDA 7.92m)
Debt / FCF = -0.43 (Net Debt -16.6m / FCF TTM 38.5m)
Total Stockholder Equity = 293.6m (last 4 quarters mean from totalStockholderEquity)
RoA = -1.21% (Net Income -4.39m / Total Assets 342.0m)
RoE = -1.50% (Net Income TTM -4.39m / Total Stockholder Equity 293.6m)
RoCE = -2.75% (EBIT -8.12m / Capital Employed (Equity 293.6m + L.T.Debt 1.16m))
RoIC = -2.10% (negative operating profit) (NOPAT -6.16m / Invested Capital 293.6m)
WACC = 7.48% (E(621.5m)/V(623.3m) * Re(7.50%) + D(1.80m)/V(623.3m) * Rd(2.16%) * (1-Tc(0.24)))
Discount Rate = 7.50% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.92%
Shares Correlation 3-Years: -100.0 | Cagr: -3.09%
[DCF] Terminal Value 77.77% ; FCFF base≈37.0m ; Y1≈31.0m ; Y5≈23.1m
[DCF] Fair Price = 30.85 (EV 475.2m - Net Debt -16.6m = Equity 491.9m / Shares 15.9m; r=7.48% [WACC]; 5y FCF grow -19.58% → 3.0% )
EPS Correlation: -86.37 | EPS CAGR: -39.39% | SUE: -1.04 | # QB: 0
Revenue Correlation: -40.25 | Revenue CAGR: -2.57% | SUE: 1.05 | # QB: 1
EPS next Quarter (2026-06-30): EPS=0.47 | Chg7d=+0.015 | Chg30d=+0.015 | Revisions Net=-1 | Analysts=2
EPS current Year (2026-12-31): EPS=1.90 | Chg7d=-0.025 | Chg30d=-0.025 | Revisions Net=+0 | Growth EPS=+125.6% | Growth Revenue=+1.4%
[Analyst] Revisions Ratio: -1.00 (0 Up / 1 Down within 30d for Next Quarter)